Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 761

1.

The reasons for termination of pregnancy in the third trimester.

Dommergues M, Benachi A, Benifla JL, des Noëttes R, Dumez Y.

Br J Obstet Gynaecol. 1999 Apr;106(4):297-303.

PMID:
10426234
2.

Fetal abnormalities leading to third trimester abortion: nine-year experience from a single medical center.

Barel O, Vaknin Z, Smorgick N, Reish O, Mendlovic S, Herman A, Maymon R.

Prenat Diagn. 2009 Mar;29(3):223-8. doi: 10.1002/pd.2188.

PMID:
19177335
3.

[Medical abortion in the second and third trimester. Report of 125 indications from 1992 to 1995].

Marret H, Perrotin F, Descamps P, de Magalhaes A, Lansac J, Body G.

J Gynecol Obstet Biol Reprod (Paris). 1999 Jun;28(3):245-52. French.

4.

Termination of pregnancy due to fetal abnormalities performed after 23 weeks' gestation: analysis of indications in 144 cases from a single medical center.

Vaknin Z, Lahat Y, Barel O, Ben-Ami I, Reish O, Herman A, Maymon R.

Fetal Diagn Ther. 2009;25(2):291-6. doi: 10.1159/000229501. Epub 2009 Jul 24.

PMID:
19628945
5.

Outcomes of congenital diaphragmatic hernia: a population-based study in Western Australia.

Colvin J, Bower C, Dickinson JE, Sokol J.

Pediatrics. 2005 Sep;116(3):e356-63. Erratum in: Pediatrics. 2006 May;117(5):1870.

PMID:
16140678
6.

Fetal karyotyping after 28 weeks of gestation for late ultrasound findings in a low risk population.

Drummond CL, Gomes DM, Senat MV, Audibert F, Dorion A, Ville Y.

Prenat Diagn. 2003 Dec 30;23(13):1068-72.

PMID:
14691994
7.
8.

Fetal hydrops and hepatosplenomegaly in the second half of pregnancy: a sign of myeloproliferative disorder in fetuses with trisomy 21.

Smrcek JM, Baschat AA, Germer U, Gloeckner-Hofmann K, Gembruch U.

Ultrasound Obstet Gynecol. 2001 May;17(5):403-9.

9.
10.

[Fetal abnormalities leading to termination of pregnancy: the experience at the Assaf Harofeh Medical Center between the years 1999-2000].

Maymon R, Sharon M, Reish O, Schneider D, Halperin R, Herman A.

Harefuah. 2003 Jun;142(6):405-9, 488. Hebrew.

PMID:
12858821
11.

[A proposed protocol for obstetrical ultrasound examination].

Novakov A, Vejnović T, Stojić S, Belopavlović Z.

Med Pregl. 1999 Sep-Oct;52(9-10):351-6. Croatian.

PMID:
10624383
12.

[Prenatal diagnosis of skeletal dysplasia: case report of a fetus with multiple anomalies].

Novakov Mikić A, Stojić S, Konstantinidis G, Ristivojević A, Krnojelac D.

Med Pregl. 2000 Mar-Apr;53(3-4):197-201. Croatian.

PMID:
10965689
13.

Efficacy of second-trimester selective termination for fetal abnormalities: international collaborative experience among the world's largest centers.

Evans MI, Goldberg JD, Dommergues M, Wapner RJ, Lynch L, Dock BS, Horenstein J, Golbus MS, Rodeck CH, Dumez Y, et al.

Am J Obstet Gynecol. 1994 Jul;171(1):90-4.

PMID:
8030739
14.

Low-dose sulprostone for pregnancy termination in cases of fetal abnormality.

Kanhai HH, Keirse MJ.

Prenat Diagn. 1993 Feb;13(2):117-21.

PMID:
8464832
15.

Risk factors for procedure-related fetal losses after mid-trimester genetic amniocentesis.

Kong CW, Leung TN, Leung TY, Chan LW, Sahota DS, Fung TY, Lau TK.

Prenat Diagn. 2006 Oct;26(10):925-30.

PMID:
16838383
18.

[Evaluation of maternal morbidity after drug-induced termination of pregnancy (TOP) after 12 gestation weeks].

Guillem P, Racinet C, Leynaud A, Benbassa A, Cans C.

J Gynecol Obstet Biol Reprod (Paris). 2003;32(3 Pt 1):227-38. French.

19.

Effect of fetal diagnosis on the outcomes of second-trimester pregnancy termination for fetal abnormalities: a pilot study.

Lo TK, Lau WL, Lai FK, Lam HS, Tse HY, Leung WC, Chin RK.

J Matern Fetal Neonatal Med. 2008 Aug;21(8):523-7. doi: 10.1080/14767050802104835.

PMID:
18609362

Supplemental Content

Support Center